Regulus Therapeutics Reports Third Quarter 2022 Financial Results and Recent Updates
/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...
United States San Diego Jay Hagan Rnas The Company Or Regulus Regulus Therapeutics Inc Exchange Commission
Source: prnewswire.com